FORA Capital’s ResMed RMD Stock Holding History

FORA Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.99M	Sell	8,853 -1,069	-11%	-$266K	0.15%	168
2025 Q4	$2.39M	Buy	9,922 +9,067	+1,060%	+$2.32M	0.29%	91
2025 Q3	$234K	Sell	855 -15,156	-95%	-$4.14M	0.04%	419
2025 Q2	$4.13M	Buy	+16,011	New	+$3.82M	0.46%	52
2023 Q4	–	Sell	-25,057	Closed	-$3.71M	–	612
2023 Q3	$3.71M	Buy	25,057 +21,172	+545%	+$3.83M	0.33%	90
2023 Q2	$849K	Sell	3,885 -5,093	-57%	-$1.14M	0.12%	180
2023 Q1	$1.97M	Buy	8,978 +914	+11%	+$198K	0.2%	144
2022 Q4	$1.68M	Buy	8,064 +5,967	+285%	+$1.31M	0.27%	101
2022 Q3	$458K	Buy	+2,097	New	+$477K	0.09%	263
2022 Q1	–	Sell	-2,698	Closed	-$703K	–	615
2021 Q4	$703K	Sell	2,698 -5,386	-67%	-$1.4M	0.27%	109
2021 Q3	$2.13M	Buy	+8,084	New	+$2.21M	0.54%	52
2020 Q4	–	Sell	-2,055	Closed	-$352K	–	1107
2020 Q3	$352K	Buy	+2,055	New	+$379K	0.23%	93
2020 Q1	–	Sell	-1,631	Closed	-$253K	–	1289
2019 Q4	$253K	Buy	+1,631	New	+$235K	0.03%	567

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FORA Capital's RMD Position: Q1 2026 in Review

FORA Capital reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $266K and leaving 8,853 shares worth $1.99M. The position accounts for 0.15% of the portfolio, ranked #168.

FORA Capital first reported a position in RMD in Q4 2019 and has held it in 13 quarters since. The position peaked at $4.13M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

FORA Capital held 8,853 shares of ResMed worth $1.99M as of Q1 2026.
FORA Capital sold 1,069 ResMed shares in Q1 2026, an estimated $266K.
ResMed made up 0.15% of FORA Capital's portfolio in Q1 2026, its #168 holding.
FORA Capital first reported a position in ResMed in Q4 2019 and has held it in 13 quarters since.
FORA Capital's ResMed position peaked at $4.13M in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.